Skip to content
DataLookout
Menu

NCT06748950

Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 4 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 8 more changesShow less
    • Start date changed from estimate of Jul 2025 to Oct 19, 2026
    • Eligibility criteria expanded, about 7 words
    • Primary completion pushed from Jul 2028 to Dec 2028
    • Study completion pushed from Jul 2028 to Jun 2029
    • Secondary endpoints revised (28)
    • Site details revised
    • Publications: details revised at 1 of 1 entry
    • Study description expanded, about 3 words
  2. Notable Start date: Mar 2025 to Jul 2025v2 Show 6 more changesShow less
    • Eligibility criteria shortened, about 40 words
    • Primary and study completion dates: Mar 2028 to Jul 2028
    • Secondary endpoints revised (28)
    • Site contact updated
    • Study title revised
    • Study description expanded, about 2 words
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

WHO-5 Well-being Index
Timeframe: Baseline through study completion, an average of 12 weeks (Arm 1: Ketogenic Diet Only) or 24 weeks (Arm 2: DAU-Ketogenic Diet Crossover).
Functioning Assessment Short Test (FAST)
Timeframe: Baseline through study completion, an average of 12 weeks (Arm 1: Ketogenic Diet Only) or 24 weeks (Arm 2: DAU-Ketogenic Diet Crossover).
Quality of Life Scale (QIDS)
Timeframe: Baseline through study completion, an average of 12 weeks (Arm 1: Ketogenic Diet Only) or 24 weeks (Arm 2: DAU-Ketogenic Diet Crossover).

Secondary (28)

MCCB - MATRICS Consensus Cognitive Battery
Montgomery-Asberg Depression Rating Scale (MADRS)
Brief Psychiatric Assessment Scale (BPRS)
Patient Health Questionnaire (PHQ-9)
Clinical Global Impressions Scale (CGI)/ Clinical Mood Monitoring
Show 23 moreShow less
Young Mania Rating Scale (YMRS)
Generalized Anxiety Disorder Scale (GAD-7)
Pittsburgh Sleep Quality Index (PSQI)
Epigenome
Mitochondrial Function
Metabolome
Proteome
Microbiome
Transcriptome
Lipidome
Blood pressure
Heart Rate Variability
Heart Rate
Weight
Waist Circumference
Total Cholesterol
Low Density Lipoprotein Cholesterol (LDL-C)
High Density Lipoprotein Cholesterol (HDL-C)
Triglycerides (TG)
Inflammatory Marker (hs-CRP)
Insulin Resistance Measure (HOMA-IR)
Glucose
Hemoglobin A1c

Arms and interventions

Arm 1: Ketogenic Diet OnlyExperimental

Participants will follow 12 weeks of the ketogenic diet, with monitoring of physical and psychological health and coaching support.

Arm 2: DAU- Ketogenic Diet CrossoverExperimental

Participants will follow 12 weeks of their usual diet (Diet-as-Usual, DAU). Then, participants will crossover and follow 12 weeks of the ketogenic diet. Monitoring of physical and psychological health and coaching support will occur throughout participation.

Other: LCHF Ketogenic Diet, Diet-as-Usual (DAU)

Sites

1 site in 1 country

  • Stanford UniversityPalo Alto, California, United States